FDA accepts generic applications for three-times-weekly Copaxone

29-08-2014

FDA accepts generic applications for three-times-weekly Copaxone

sheff / Shutterstock.com

The US Food and Drug Administration (FDA) has accepted applications by generic drug makers Mylan and Novartis subsidiary Sandoz for a three-times-weekly version of blockbuster drug Copaxone (glatiramer acetate), it was announced yesterday.


FDA, Copaxone, Teva, Mylan, ANDA

LSIPR